Form 4: RA Capital Management Reports Beneficial Ownership Changes in Nkarta, Inc.

RA Capital Management and related entities report changes in beneficial ownership of Nkarta, Inc. stock, including the grant of a stock option to Dr. Zachary Scheiner.

Summary

• RA Capital Management, L.P., along with related entities including RA Capital Healthcare Fund, L.P., RA Capital Nexus Fund, L.P., Peter Kolchinsky, and Rajeev Shah, filed a Form 4 detailing changes in beneficial ownership of Nkarta, Inc. (NKTX) securities.
• The report discloses the grant of a stock option to Dr. Zachary Scheiner on June 13, 2024, for 22,500 shares of Nkarta's common stock at an exercise price of $6.23.
• The option vests fully on the earlier of June 13, 2025, or the day before the first annual meeting of Nkarta's stockholders after the grant date, contingent on Dr. Scheiner's continued service.
• Vesting will accelerate upon a change in control of Nkarta or Dr. Scheiner's separation from service due to death or disability.
• Dr. Scheiner holds the option for the benefit of RA Capital Healthcare Fund and RA Capital Nexus Fund and is obligated to remit any proceeds from exercising the option to offset advisory fees.
• RA Capital Management, L.P. is the investment manager for RA Capital Healthcare Fund, L.P. and RA Capital Nexus Fund, L.P.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, so the sentiment is neutral. It simply reports transactions and ownership details.

Positives

• The grant of stock options to a board member could align interests with shareholders.

Industry Context

This filing is a routine disclosure related to changes in beneficial ownership, common in the biotechnology industry where equity compensation is frequently used.

Stakeholder Impact

• The grant of stock options could potentially align the interests of the board member with those of the shareholders.

Key Dates